Edison, NJ — PIC/S GMP-certified palm phytonutrients producer ExcelVite has completed the quality/audit inspection of its Malaysian production site by the U.S. Food and Drug Administration.
The FDA inspection included both ExcelVite’s production plant and Quality Management System. Both were found in compliance with the FDA’s Title 21 Current Good Manufacturing Practices (21 CF-cGMP).
“As part of the company’s commitment to ensure that our QMS is compliant with current good manufacturing practice (cGMP), we are proud to know that our existing system meets the quality criteria and requirements of the US FDA. It is of utmost importance to ensure that the entire system is adhered to and implemented at all times in order to ensure product quality and safety, which is our commitment to customers,” said YT Chan, ExcelVite Quality Assurance Manage, in a statement from the company.
ExcelVite manufactures and exports EVNol™ natural full spectrum tocotrienol complex and EVTene™ natural mixed-carotene complex. This is the second time the U.S. FDA has inspected ExcelVite’s manufacturing facility in Chemor, Perak, Malaysia. The first occurred in 2012.